Traduction de «Groupe de conseillers médicaux de la CCEA » (Français → Anglais) :

(Return tabled) Question No. 90 Hon. Carolyn Bennett: With respect to the Expert Review Panel on Medical Isotope Production: (a) what were the criteria and rationale to choose the four members of the panel; (b) who declined to sit on the panel; (c) how many times did the panel meet; (d) who did the panel consult; (e) what was the formal mandate of the panel; (f) did the panel have the technical expertise alone to be able to understand the proposals and make recommendations; (g) what is the relation of Dr. Alexander MacEwan, the Special Advisor on Medical Isotopes to the Minister of Health, to the panel; (h) did the panel recommend to the Minister that she implement the four recommendations of the Canadian Association of Nuclear Medic ...[+++]ine mentioned at the November 23rd meeting of the Standing Committee on Health; (i) what was the process for the panel to consult with provinces and territories; (j) did the panel consult and meet with each public and private consortium that made a submission to better understand the strengths and weaknesses of their proposal; (k) will the government release the 22 submissions on ideas for isotope supply that were received and reviewed by the panel; (l) what was the role of the firm SECOR in the production of the expert panel report; (m) who, from SECOR, was assigned to this task; (n) what were the recommendations of the panel’s November 30th report to the government; (o) will the panel be dismantled or will it continue its advising role to the government following its November 30th report; and (p) what will be the outcome of the panel and the government’s next steps including, but not limited to, recommendations to proceed with projects, funding recommendations, or another phase of evaluations?

It is an active member of the World Health Organization (WHO) International Medical Products Anti-Counterfeiting Task Force (IMPACT)[24], which has delivered principles on legislation against counterfeit medical products, and furthermore the Group of Specialists on Counterfeit Pharmaceutical Products (PC-S-CP) of the Council of Europe.

IVLARGE COMBUSTION PLANTS PAGEREF _Toc469982226 \h IVSTRATEGIC ENVIRONMENTAL IMPACT ASSESSMENT (SEA) PAGEREF _Toc469982227 \h VLIMIT VALUES FOR BENZENE AND CARBON MONOXIDE IN AMBIENT AIR PAGEREF _Toc469982228 \h VIBIOSAFETY PROTOCOL - COUNCIL CONCLUSIONS PAGEREF _Toc469982229 \h VIIOVERALL ASSESSMENT OF THE 5th ACTION PROGRAMME AND ENVIRONMENTAL SECTORAL INDICATORS PAGEREF _Toc469982230 \h VIIINATIONAL EMISSION CEILINGS AND OZONE IN AMBIENT AIR PAGEREF _Toc469982231 \h VIIICOMMISSION WORK PROGRAMME FOR THE YEAR 2000 PAGEREF _Toc469982232 \h IXCOMMUNITY STRATEGY ON CHEMICAL PRODUCTS PAGEREF _Toc469982233 \h IXANY OTHER BUSINESS PAGEREF _Toc469982234 \h X?Brominated flame retardants PAGEREF _Toc469982235 \h X?Operation "In town without my car ...[+++]" PAGEREF _Toc469982236 \h X?Promotion of sustainable urban development PAGEREF _Toc469982237 \h XPOINT DISCUSSED IN THE MARGINS PAGEREF _Toc469982238 \h X?Presidency conclusions on Balkans Task Force Final Report PAGEREF _Toc469982239 \h XITEMS APPROVED WITHOUT DEBATETRADE PAGEREF _Toc469982241 \h XI--Canary Islands - Application of the provisions of Community law PAGEREF _Toc469982242 \h XI--Anti-dumping : Atlantic salmon originating in Norway PAGEREF _Toc469982243 \h XIEEA PAGEREF _Toc469982244 \h XI--Decision of the EEA Joint Committee amending Annex VII to the EEA Agreement (Mutual recognition of professional qualification) PAGEREF _Toc469982245 \h XICOMMODITIES PAGEREF _Toc469982246 \h XI--Lead and Zinc PAGEREF _Toc469982247 \h XIHEALTH PAGEREF _Toc469982248 \h XI--Medical devices PAGEREF _Toc469982249 \h XIYOUTH PAGEREF _Toc469982250 \h XII--DAPHNE Programme * PAGEREF _Toc469982251 \h XIIJUSTICE AND HOME AFFAIRS PAGEREF _Toc469982252 \h XII--Schengen acquis in Greece PAGEREF _Toc469982253 \h XIIBUDGET PAGEREF _Toc469982254 \h XII--Financial Regulation - 8th set of modifications PAGEREF _Toc469982255 \h XIITRANSPARENCY PAGEREF _Toc469982256 \h XIII--Public access to Council documents PAGEREF _Toc469982257 \h XIIIEQUALITY OF ...

to consider restricting the use of DEHP in medical devices giving rise to possible exposure of neonates and identified groups of concern following the procedure laid down in Council Directive 93/42/EEC (35) concerning medical devices, assuming the availability of safe alternatives.

As a first step, the Group will work on the basis of the priority themes mentioned in the Commission report for the December 1994 Essen European Council : - qualitative and quantitative impact of the introduction of new information and communication technologies on employment, and conditions for optimal exploitation of new sources of employment linked to technological progress, - impact of new technologies on work organisation (flexible enterprise, teleworking) and potential consequences on social legislation (labour law, social secur ...[+++]ity, including health and safety at work), - consequences of the information society on the cohesion of Europe's regions and towns, - opportunities offered by new technologies for adaptation of education systems to the needs of the information society, - opportunities offered by new technologies for improving management of systems devoted to healthcare and quality medical care ; and - opportunities offered by new technologies for improving the labour market situation and developing human resources.

ensure that the High-Level Group on Health Services and Medical Care will work, as appropriate, in cooperation with other relevant bodies and committees, in particular the Social Protection Committee and the Economic Policy Committee; consider further initiatives on patient mobility and health care developments within the European Union to provide data for informed decisions on further trans-national cooperation; and ensure cooperation and co-ordination between relevant international bodies including the World Health Organisation, t ...[+++]he Organisation for Economic Cooperation and Development and the Council of Europe.